Type 2 & other diabetes

Inpatient Diet Orders and Continuous Glucose Monitoring in Noncritically Ill, Hospitalized Adult Patients

Endocr PractPublished Secondary analysis of a prospective observational study

Authors' conclusion

Inpatient diet orders are modestly associated with 24-hour CGM-derived glycemic measures adjusted by insulin therapy and other related medications. Future research is needed to standardize diet order classifications and assess their impact on inpatient glycemic management.

Study context

Population
Noncritically ill hospitalized adults, primarily medical units; mean age 60.7 years, BMI 38.5 kg/m², 36.4% female, 77.4% T2Danalytical sample
Participants
283 participants
Comparison
Inpatient diet order categories vs regular diet
Primary endpoint
Percent TIR (70-180 mg/dL)
Methodological detailsmultivariate linear mixed-effects models, Diet orders extracted from clinical documentation and standardized into 11 general categories
  • Multivariate linear mixed-effects models
  • Diet orders extracted from clinical documentation and standardized into 11 general categories

Primary result

As reported in the abstract

TIR
  • Regular diet with restrictions associated with lower TIR vs regular diet
  • Adjusted for demographics, insulin therapy and other relevant medications

Secondary outcomes

TAR

Regular diet with restrictions associated with higher TAR vs regular diet

TBR

Diabetic and liquid diets associated with higher TBR vs regular diet

Glycemic variability

Glucose variability did not differ across diet orders

Continuous glucose monitoring (CGM) measures and insulin therapy use

CGM-derived glycemic measures and insulin therapy use varied significantly across diet orders

Original publication

Inpatient Diet Orders and Continuous Glucose Monitoring in Noncritically Ill, Hospitalized Adult Patients. Endocr Pract. Published 11 September 2025. doi:10.1016/j.eprac.2025.09.002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.